Marwa Eid
Cairo, 2011, Egypt
NCT Number: NCT04498312
To determine whether extracorporeal shock wave therapy (ESWT) or manual lymphatic drainage (MLD) is more effective for decreasing post-liposuction cellulite.
Thirty females with grade 3 cellulite were randomly distributed into two equal groups: group A (ESWT group) (n=15) and group B (MLD group) (n=15). The cellulite grade was assessed by using the cellulite grading scale, and the thickness of subcutaneous fat was assessed by the skinfold caliper. The assessment was carried out before starting the treatment and after 4 weeks. All participants received treatment 2 times/ week for 4 weeks.
Looking for future studies?
Notify Me25 year–45 year
Female
Interventional
Not applicable
Cairo, 2011, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participant was placed into supine lying position then the head of the shock wave was applied on the anterior or posterior aspect of the thigh which was scanned with 2000 shots for both horizontal direction and vertical direction. The period of each session was 15 minutes, 2 times/week for 4 weeks
Other names: Manual lymphatic drainage
Time frame: 4 weeks
Cellulite grading scale grade 0: means a smooth surface of the skin while standing, grade 1: means mattress phenomena upon pinch-test, grade 2: means mattress phenomena spontaneously while standing, grade 3: means mattress phenomena while in standing and lying position Higher score means bad progression
Cairo University
Other
Comparison of Extracorporeal Shock Wave Therapy Versus Manual Lymphatic Drainage on Cellulite Post Liposuction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05836779
Cellulite, Pathological Conditions, Signs and Symptoms
Encinitas, California, United States
View Trial DetailsNCT07675356
Cellulite, Gynoid Lipodystrophy
Mysłowice, Poland
View Trial DetailsNCT05026216
Cellulite, Pathological Conditions, Signs and Symptoms
Westport, Connecticut, United States
View Trial DetailsNCT06791564
Cellulite, Cellulite Reduction
Miami, Florida, United States
View Trial Details